Literature DB >> 6610388

Development of resistance to cephalosporins in clinical strains of Citrobacter spp.

T D Gootz, D B Jackson, J C Sherris.   

Abstract

The predominant beta-lactam antibiogram of Citrobacter freundii resembles that of Enterobacter cloacae in demonstrating resistance to cephalothin and cefoxitin with susceptibility to the newer cephalosporins. Four representative strains of C. freundii were reversibly induced to high-level beta-lactamase production by cefoxitin, and mutants with stable, high-level production were selected with cefamandole. The mutants were resistant to several second- and third-generation cephalosporins. Comparisons of isoelectric points and substrate profiles of beta-lactamases from wild-type, induced wild-type, and mutant organisms suggested a close relationship to those from E. cloacae and indicated that C. freundii mutants, like those of E. cloacae, were derepressed for production of beta-lactamase. One primary isolate of C. freundii resembled the mutants in all characteristics. In contrast, most strains of Citrobacter diversus were susceptible to all cephalosporins, and two representative strains showed neither inducible nor mutational resistance. Cefoxitin induction to enhanced beta-lactamase production was demonstrated in a cephalothin-resistant isolate, and a derepressed mutant was selected with cefotaxime. The beta-lactamase from this C. diversus strain differed substantially in substrate profile from that of E. cloacae and C. freundii.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6610388      PMCID: PMC185593          DOI: 10.1128/AAC.25.5.591

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Thermolabile repression of cephalosporinase synthesis in Citrobacter freundii.

Authors:  T Sawai; S Nakajima; T Morohoshi; S Yamagishi
Journal:  Microbiol Immunol       Date:  1977-11       Impact factor: 1.955

2.  Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.

Authors:  R V Goering; C C Sanders; W Sanders
Journal:  J Antibiot (Tokyo)       Date:  1978-04       Impact factor: 2.649

3.  Susceptibility of Enterobacter to cefamandole: evidence for a high mutation rate to resistance.

Authors:  C M Findell; J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

4.  Mechanism of synergistic action of a combination of ampicillin and dicloxacillin against a beta-lactamase-producing strain of Citrobacter freundii.

Authors:  J Mizoguchi; H Suginaka; S Kotani
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

5.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

Review 6.  The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics.

Authors:  R B Sykes; M Matthew
Journal:  J Antimicrob Chemother       Date:  1976-06       Impact factor: 5.790

7.  Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae.

Authors:  S Minami; A Yotsuji; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

8.  Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.

Authors:  C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

9.  Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.

Authors:  D G Beckwith; J A Jahre
Journal:  J Clin Microbiol       Date:  1980-10       Impact factor: 5.948

10.  Dissociated resistance among cephalosporins.

Authors:  P M Waterworth; A M Emmerson
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

View more
  13 in total

1.  Cloning, sequencing and analysis of the structural gene and regulatory region of the Pseudomonas aeruginosa chromosomal ampC beta-lactamase.

Authors:  J M Lodge; S D Minchin; L J Piddock; S J Busby
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

Review 2.  Discovery and development of new antimicrobial agents.

Authors:  T D Gootz
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

3.  John C. Sherris, M.D.

Authors:  Alexander J McAdam
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

Review 4.  Clinical importance of inducible beta-lactamases in gram-negative bacteria.

Authors:  C C Sanders; W E Sanders
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

5.  In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor.

Authors:  K Coleman; D R Griffin; J W Page; P A Upshon
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

6.  In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori.

Authors:  A A van Zwet; J C Thijs; W Schievink-de Vries; J Schiphuis; J A Snijder
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

7.  Septicaemia caused by an Enterobacter cloacae strain varying in resistance against cephalosporins.

Authors:  B M Andersen; I M Dahl; R C George; A Gilfillian
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

8.  Inactivation of the ampD gene causes semiconstitutive overproduction of the inducible Citrobacter freundii beta-lactamase.

Authors:  F Lindberg; S Lindquist; S Normark
Journal:  J Bacteriol       Date:  1987-05       Impact factor: 3.490

9.  Common mechanism of ampC beta-lactamase induction in enterobacteria: regulation of the cloned Enterobacter cloacae P99 beta-lactamase gene.

Authors:  F Lindberg; S Normark
Journal:  J Bacteriol       Date:  1987-02       Impact factor: 3.490

10.  Novel class A beta-lactamase Sed-1 from Citrobacter sedlakii: genetic diversity of beta-lactamases within the Citrobacter genus.

Authors:  S Petrella; D Clermont; I Casin; V Jarlier; W Sougakoff
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.